[Clinical experience with the combination of sulfamethoxazole and trimethoprim in gynecology and obstetrics].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D004357:Drug Synergism; D004716:Endometritis / Q000188:drug therapy; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D005831:Genital Diseases, Female / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy; D010538:Peritonitis / Q000188:drug therapy; D010922:Placenta Diseases / Q000188:drug therapy; D011183:Postoperative Complications / Q000188:drug therapy; D011247:Pregnancy; D011743:Pyrimidines / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D013530:Surgical Wound Infection / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy*; D014627:Vaginitis / Q000188:drug therapy
D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013420:Sulfamethoxazole
Klinische Erfahrungen mit einem neuen Kombinationspräparat aus Sulfamethoxazol and Trimethoprim in Gynäkologie und Geburtshilfe.